Industry Research Reports

Home > Reports > Service & Software > Global Tissue-Based Diagnostics Market Research Report 2026

Global Tissue-Based Diagnostics Market Research Report 2026

Industry: Service & Software

Published Date: 2026-04-21

Pages: 110 Pages

Report ld: 6600994

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Tissue-Based Diagnostics Market Size(US$)

CAGR 2026-2032

6.7%

Market Size,2032

USD 9,601

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 6,506 million

Market Forecast in 2032(Value)

US$ 9,601 million

CAGR

6.7%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Tissue-Based Diagnostics market was valued at US$ 6136 million in 2025 and is anticipated to reach US$ 9601 million by 2032, at a CAGR of 6.7% from 2026 to 2032.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report delivers a comprehensive overview of the global Tissue-Based Diagnostics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Tissue-Based Diagnostics. The Tissue-Based Diagnostics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Tissue-Based Diagnostics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Tissue-Based Diagnostics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

Roche
Danaher
Thermo Fisher Scientific
Abbott
Agilent Technologies
ABCAM
Merck
BD
Hologic
Bio Rad

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Digital Pathology and Workflow Management
Special Staining

Segment by Application

Hospitals
Research Laboratories
Pharmaceutical Companies
Contract Research Organizations
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

Chapter 3: Provides a detailed view of the competitive landscape for Tissue-Based Diagnostics companies, covering revenue share, development plans, and mergers and acquisitions.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tissue-Based Diagnostics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Immunohistochemistry (IHC)

1.2.3 In Situ Hybridization (ISH)

1.2.4 Digital Pathology and Workflow Management

1.2.5 Special Staining

1.3 Market by Application

1.3.1 Global Tissue-Based Diagnostics Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospitals

1.3.3 Research Laboratories

1.3.4 Pharmaceutical Companies

1.3.5 Contract Research Organizations

1.3.6 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tissue-Based Diagnostics Market Perspective (2021–2032)

2.2 Global Tissue-Based Diagnostics Growth Trends by Region

2.2.1 Global Tissue-Based Diagnostics Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Tissue-Based Diagnostics Historic Market Size by Region (2021–2026)

2.2.3 Tissue-Based Diagnostics Forecasted Market Size by Region (2027–2032)

2.3 Tissue-Based Diagnostics Market Dynamics

2.3.1 Tissue-Based Diagnostics Industry Trends

2.3.2 Tissue-Based Diagnostics Market Drivers

2.3.3 Tissue-Based Diagnostics Market Challenges

2.3.4 Tissue-Based Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Tissue-Based Diagnostics Players by Revenue

3.1.1 Global Top Tissue-Based Diagnostics Players by Revenue (2021–2026)

3.1.2 Global Tissue-Based Diagnostics Revenue Market Share by Players (2021–2026)

3.2 Global Top Tissue-Based Diagnostics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Tissue-Based Diagnostics Revenue

3.4 Global Tissue-Based Diagnostics Market Concentration Ratio

3.4.1 Global Tissue-Based Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tissue-Based Diagnostics Revenue in 2025

3.5 Global Key Players of Tissue-Based Diagnostics Head Offices and Areas Served

3.6 Global Key Players of Tissue-Based Diagnostics, Products and Applications

3.7 Global Key Players of Tissue-Based Diagnostics, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Tissue-Based Diagnostics Breakdown Data by Type

4.1 Global Tissue-Based Diagnostics Historic Market Size by Type (2021–2026)

4.2 Global Tissue-Based Diagnostics Forecasted Market Size by Type (2027–2032)

5 Tissue-Based Diagnostics Breakdown Data by Application

5.1 Global Tissue-Based Diagnostics Historic Market Size by Application (2021–2026)

5.2 Global Tissue-Based Diagnostics Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Tissue-Based Diagnostics Market Size (2021–2032)

6.2 North America Tissue-Based Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Tissue-Based Diagnostics Market Size by Country (2021–2026)

6.4 North America Tissue-Based Diagnostics Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Tissue-Based Diagnostics Market Size (2021–2032)

7.2 Europe Tissue-Based Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Tissue-Based Diagnostics Market Size by Country (2021–2026)

7.4 Europe Tissue-Based Diagnostics Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Tissue-Based Diagnostics Market Size (2021–2032)

8.2 Asia-Pacific Tissue-Based Diagnostics Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Tissue-Based Diagnostics Market Size by Region (2021–2026)

8.4 Asia-Pacific Tissue-Based Diagnostics Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Tissue-Based Diagnostics Market Size (2021–2032)

9.2 Latin America Tissue-Based Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Tissue-Based Diagnostics Market Size by Country (2021–2026)

9.4 Latin America Tissue-Based Diagnostics Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Tissue-Based Diagnostics Market Size (2021–2032)

10.2 Middle East & Africa Tissue-Based Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Tissue-Based Diagnostics Market Size by Country (2021–2026)

10.4 Middle East & Africa Tissue-Based Diagnostics Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Tissue-Based Diagnostics Introduction

11.1.4 Roche Revenue in Tissue-Based Diagnostics Business (2021–2026)

11.1.5 Roche Recent Development

11.2 Danaher

11.2.1 Danaher Company Details

11.2.2 Danaher Business Overview

11.2.3 Danaher Tissue-Based Diagnostics Introduction

11.2.4 Danaher Revenue in Tissue-Based Diagnostics Business (2021–2026)

11.2.5 Danaher Recent Development

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Details

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific Tissue-Based Diagnostics Introduction

11.3.4 Thermo Fisher Scientific Revenue in Tissue-Based Diagnostics Business (2021–2026)

11.3.5 Thermo Fisher Scientific Recent Development

11.4 Abbott

11.4.1 Abbott Company Details

11.4.2 Abbott Business Overview

11.4.3 Abbott Tissue-Based Diagnostics Introduction

11.4.4 Abbott Revenue in Tissue-Based Diagnostics Business (2021–2026)

11.4.5 Abbott Recent Development

11.5 Agilent Technologies

11.5.1 Agilent Technologies Company Details

11.5.2 Agilent Technologies Business Overview

11.5.3 Agilent Technologies Tissue-Based Diagnostics Introduction

11.5.4 Agilent Technologies Revenue in Tissue-Based Diagnostics Business (2021–2026)

11.5.5 Agilent Technologies Recent Development

11.6 ABCAM

11.6.1 ABCAM Company Details

11.6.2 ABCAM Business Overview

11.6.3 ABCAM Tissue-Based Diagnostics Introduction

11.6.4 ABCAM Revenue in Tissue-Based Diagnostics Business (2021–2026)

11.6.5 ABCAM Recent Development

11.7 Merck

11.7.1 Merck Company Details

11.7.2 Merck Business Overview

11.7.3 Merck Tissue-Based Diagnostics Introduction

11.7.4 Merck Revenue in Tissue-Based Diagnostics Business (2021–2026)

11.7.5 Merck Recent Development

11.8 BD

11.8.1 BD Company Details

11.8.2 BD Business Overview

11.8.3 BD Tissue-Based Diagnostics Introduction

11.8.4 BD Revenue in Tissue-Based Diagnostics Business (2021–2026)

11.8.5 BD Recent Development

11.9 Hologic

11.9.1 Hologic Company Details

11.9.2 Hologic Business Overview

11.9.3 Hologic Tissue-Based Diagnostics Introduction

11.9.4 Hologic Revenue in Tissue-Based Diagnostics Business (2021–2026)

11.9.5 Hologic Recent Development

11.10 Bio Rad

11.10.1 Bio Rad Company Details

11.10.2 Bio Rad Business Overview

11.10.3 Bio Rad Tissue-Based Diagnostics Introduction

11.10.4 Bio Rad Revenue in Tissue-Based Diagnostics Business (2021–2026)

11.10.5 Bio Rad Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Tissue-Based Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Immunohistochemistry (IHC)

Table 3. Key Players of In Situ Hybridization (ISH)

Table 4. Key Players of Digital Pathology and Workflow Management

Table 5. Key Players of Special Staining

Table 6. Global Tissue-Based Diagnostics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Tissue-Based Diagnostics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Tissue-Based Diagnostics Market Size by Region (US$ Million), 2021–2026

Table 9. Global Tissue-Based Diagnostics Market Share by Region (2021–2026)

Table 10. Global Tissue-Based Diagnostics Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Tissue-Based Diagnostics Market Share by Region (2027–2032)

Table 12. Tissue-Based Diagnostics Market Trends

Table 13. Tissue-Based Diagnostics Market Drivers

Table 14. Tissue-Based Diagnostics Market Challenges

Table 15. Tissue-Based Diagnostics Market Restraints

Table 16. Global Tissue-Based Diagnostics Revenue by Players (US$ Million), 2021–2026

Table 17. Global Tissue-Based Diagnostics Market Share by Players (2021–2026)

Table 18. Global Top Tissue-Based Diagnostics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Tissue-Based Diagnostics Revenue, 2025

Table 19. Ranking of Global Top Tissue-Based Diagnostics Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Tissue-Based Diagnostics Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Tissue-Based Diagnostics, Headquarters and Area Served

Table 22. Global Key Players of Tissue-Based Diagnostics, Products and Applications

Table 23. Global Key Players of Tissue-Based Diagnostics, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Tissue-Based Diagnostics Market Size by Type (US$ Million), 2021–2026

Table 26. Global Tissue-Based Diagnostics Revenue Market Share by Type (2021–2026)

Table 27. Global Tissue-Based Diagnostics Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Tissue-Based Diagnostics Revenue Market Share by Type (2027–2032)

Table 29. Global Tissue-Based Diagnostics Market Size by Application (US$ Million), 2021–2026

Table 30. Global Tissue-Based Diagnostics Revenue Market Share by Application (2021–2026)

Table 31. Global Tissue-Based Diagnostics Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Tissue-Based Diagnostics Revenue Market Share by Application (2027–2032)

Table 33. North America Tissue-Based Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Tissue-Based Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 35. North America Tissue-Based Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Tissue-Based Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Tissue-Based Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Tissue-Based Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Tissue-Based Diagnostics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Tissue-Based Diagnostics Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Tissue-Based Diagnostics Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Tissue-Based Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Tissue-Based Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Tissue-Based Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Tissue-Based Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Tissue-Based Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Tissue-Based Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 48. Roche Company Details

Table 49. Roche Business Overview

Table 50. Roche Tissue-Based Diagnostics Product

Table 51. Roche Revenue in Tissue-Based Diagnostics Business (US$ Million), 2021–2026

Table 52. Roche Recent Development

Table 53. Danaher Company Details

Table 54. Danaher Business Overview

Table 55. Danaher Tissue-Based Diagnostics Product

Table 56. Danaher Revenue in Tissue-Based Diagnostics Business (US$ Million), 2021–2026

Table 57. Danaher Recent Development

Table 58. Thermo Fisher Scientific Company Details

Table 59. Thermo Fisher Scientific Business Overview

Table 60. Thermo Fisher Scientific Tissue-Based Diagnostics Product

Table 61. Thermo Fisher Scientific Revenue in Tissue-Based Diagnostics Business (US$ Million), 2021–2026

Table 62. Thermo Fisher Scientific Recent Development

Table 63. Abbott Company Details

Table 64. Abbott Business Overview

Table 65. Abbott Tissue-Based Diagnostics Product

Table 66. Abbott Revenue in Tissue-Based Diagnostics Business (US$ Million), 2021–2026

Table 67. Abbott Recent Development

Table 68. Agilent Technologies Company Details

Table 69. Agilent Technologies Business Overview

Table 70. Agilent Technologies Tissue-Based Diagnostics Product

Table 71. Agilent Technologies Revenue in Tissue-Based Diagnostics Business (US$ Million), 2021–2026

Table 72. Agilent Technologies Recent Development

Table 73. ABCAM Company Details

Table 74. ABCAM Business Overview

Table 75. ABCAM Tissue-Based Diagnostics Product

Table 76. ABCAM Revenue in Tissue-Based Diagnostics Business (US$ Million), 2021–2026

Table 77. ABCAM Recent Development

Table 78. Merck Company Details

Table 79. Merck Business Overview

Table 80. Merck Tissue-Based Diagnostics Product

Table 81. Merck Revenue in Tissue-Based Diagnostics Business (US$ Million), 2021–2026

Table 82. Merck Recent Development

Table 83. BD Company Details

Table 84. BD Business Overview

Table 85. BD Tissue-Based Diagnostics Product

Table 86. BD Revenue in Tissue-Based Diagnostics Business (US$ Million), 2021–2026

Table 87. BD Recent Development

Table 88. Hologic Company Details

Table 89. Hologic Business Overview

Table 90. Hologic Tissue-Based Diagnostics Product

Table 91. Hologic Revenue in Tissue-Based Diagnostics Business (US$ Million), 2021–2026

Table 92. Hologic Recent Development

Table 93. Bio Rad Company Details

Table 94. Bio Rad Business Overview

Table 95. Bio Rad Tissue-Based Diagnostics Product

Table 96. Bio Rad Revenue in Tissue-Based Diagnostics Business (US$ Million), 2021–2026

Table 97. Bio Rad Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Tissue-Based Diagnostics Picture

Figure 2. Global Tissue-Based Diagnostics Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Tissue-Based Diagnostics Market Share by Type: 2025 vs 2032

Figure 4. Immunohistochemistry (IHC) Features

Figure 5. In Situ Hybridization (ISH) Features

Figure 6. Digital Pathology and Workflow Management Features

Figure 7. Special Staining Features

Figure 8. Global Tissue-Based Diagnostics Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Tissue-Based Diagnostics Market Share by Application: 2025 vs 2032

Figure 10. Hospitals Case Studies

Figure 11. Research Laboratories Case Studies

Figure 12. Pharmaceutical Companies Case Studies

Figure 13. Contract Research Organizations Case Studies

Figure 14. Other Case Studies

Figure 15. Tissue-Based Diagnostics Report Years Considered

Figure 16. Global Tissue-Based Diagnostics Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 17. Global Tissue-Based Diagnostics Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 18. Global Tissue-Based Diagnostics Market Share by Region: 2025 vs 2032

Figure 19. Global Tissue-Based Diagnostics Market Share by Players in 2025

Figure 20. Global Tissue-Based Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. The Top 10 and 5 Players Market Share by Tissue-Based Diagnostics Revenue in 2025

Figure 22. North America Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. North America Tissue-Based Diagnostics Market Share by Country (2021–2032)

Figure 24. United States Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Canada Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Europe Tissue-Based Diagnostics Market Share by Country (2021–2032)

Figure 28. Germany Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. France Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. U.K. Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Italy Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Russia Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Ireland Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Asia-Pacific Tissue-Based Diagnostics Market Share by Region (2021–2032)

Figure 36. China Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Japan Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. South Korea Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Southeast Asia Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. India Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Australia & New Zealand Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Latin America Tissue-Based Diagnostics Market Share by Country (2021–2032)

Figure 44. Mexico Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Brazil Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Middle East & Africa Tissue-Based Diagnostics Market Share by Country (2021–2032)

Figure 48. Israel Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Saudi Arabia Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. UAE Tissue-Based Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Roche Revenue Growth Rate in Tissue-Based Diagnostics Business (2021–2026)

Figure 52. Danaher Revenue Growth Rate in Tissue-Based Diagnostics Business (2021–2026)

Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Tissue-Based Diagnostics Business (2021–2026)

Figure 54. Abbott Revenue Growth Rate in Tissue-Based Diagnostics Business (2021–2026)

Figure 55. Agilent Technologies Revenue Growth Rate in Tissue-Based Diagnostics Business (2021–2026)

Figure 56. ABCAM Revenue Growth Rate in Tissue-Based Diagnostics Business (2021–2026)

Figure 57. Merck Revenue Growth Rate in Tissue-Based Diagnostics Business (2021–2026)

Figure 58. BD Revenue Growth Rate in Tissue-Based Diagnostics Business (2021–2026)

Figure 59. Hologic Revenue Growth Rate in Tissue-Based Diagnostics Business (2021–2026)

Figure 60. Bio Rad Revenue Growth Rate in Tissue-Based Diagnostics Business (2021–2026)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Tissue-Based Diagnostics market? zhanKai

The top companies in the global Tissue-Based Diagnostics market are Roche、Danaher、Thermo Fisher Scientific.

What was the global market size of Tissue-Based Diagnostics in 2026? shouQi

What is the annual compound growth rate of the global Tissue-Based Diagnostics market size from 2026 to 2032? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Tissue-Based Diagnostics in 2032? shouQi

Related Reports

Tissue-Based Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 6136 million in 2025 and is projected to reach US$ 9601 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-07-09
Pages: 105
USD 3950.00
(Single User License)
Global Tissue-Based Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tissue-Based Diagnostics market is projected to grow from US$ 5787 million in 2024 to US$ 9055 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-25
Pages: 129
USD 4900.00
(Single User License)
Global Tissue-Based Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tissue-Based Diagnostics market size was US$ 5787 million in 2024 and is forecast to a readjusted size of US$ 9055 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 78
USD 4250.00
(Single User License)
Tissue-Based Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 5787 million in 2024 and is forecast to a readjusted size of US$ 9055 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 99
USD 3950.00
(Single User License)
Global Tissue-Based Diagnostics Market Research Report 2025
The global market for Tissue-Based Diagnostics was valued at US$ 5787 million in the year 2024 and is projected to reach a revised size of US$ 9055 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published Date: 2025-02-21
Pages: 72
USD 2900.00
(Single User License)
Global Tissue-Based Diagnostics Market Insights, Forecast to 2030
Market Analysis and Insights: Global Tissue-Based Diagnostics Market
Published Date: 2024-04-08
Pages: 110
USD 4900.00
(Single User License)
Tissue-Based Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 5321 million in 2023 and is forecast to a readjusted size of US$ 8054.2 million by 2030 with a CAGR of 6.7% during the forecast period 2024-2030
Published Date: 2024-02-22
Pages: 110
USD 3950.00
(Single User License)
Global Tissue-Based Diagnostics Market Research Report 2024
The global Tissue-Based Diagnostics market was valued at US$ 5321 million in 2023 and is anticipated to reach US$ 8054.2 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
Published Date: 2024-02-06
Pages: 81
USD 2900.00
(Single User License)

Tissue-Based Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 6136 million in 2025 and is projected to reach US$ 9601 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-07-09
Pages: 105
USD 3950.00 (Single User License)
Global Tissue-Based Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tissue-Based Diagnostics market is projected to grow from US$ 5787 million in 2024 to US$ 9055 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-25
Pages: 129
USD 4900.00 (Single User License)
Global Tissue-Based Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tissue-Based Diagnostics market size was US$ 5787 million in 2024 and is forecast to a readjusted size of US$ 9055 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 78
USD 4250.00 (Single User License)
Tissue-Based Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 5787 million in 2024 and is forecast to a readjusted size of US$ 9055 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 99
USD 3950.00 (Single User License)
Global Tissue-Based Diagnostics Market Research Report 2025
The global market for Tissue-Based Diagnostics was valued at US$ 5787 million in the year 2024 and is projected to reach a revised size of US$ 9055 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published: 2025-02-21
Pages: 72
USD 2900.00 (Single User License)
Global Tissue-Based Diagnostics Market Insights, Forecast to 2030
Market Analysis and Insights: Global Tissue-Based Diagnostics Market
Published: 2024-04-08
Pages: 110
USD 4900.00 (Single User License)
Tissue-Based Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 5321 million in 2023 and is forecast to a readjusted size of US$ 8054.2 million by 2030 with a CAGR of 6.7% during the forecast period 2024-2030
Published: 2024-02-22
Pages: 110
USD 3950.00 (Single User License)
Global Tissue-Based Diagnostics Market Research Report 2024
The global Tissue-Based Diagnostics market was valued at US$ 5321 million in 2023 and is anticipated to reach US$ 8054.2 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
Published: 2024-02-06
Pages: 81
USD 2900.00 (Single User License)